arrow_back Back to App

September Designated Sickle Cell Disease Awareness Month: Congressional Support

The U.S. Congress expresses support for designating September as Sickle Cell Disease Awareness Month. The goal is to educate communities about the disease, the need for research, and better treatments. It calls for ensuring equal access to new therapies, especially within Medicaid and Medicare programs.
Key points
September recognized as Sickle Cell Disease Awareness Month for public education.
Support for research into the disease and finding effective treatments.
Call to improve access to modern therapies for patients, including through government insurance.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_494
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2021-06-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 2021 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_494.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-23.

What are the main provisions?

Key points include:

  • September recognized as Sickle Cell Disease Awareness Month for public education.
  • Support for research into the disease and finding effective treatments.
  • Call to improve access to modern therapies for patients, including through government insurance.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health